Nucrogene Pharmaceuticals Inc, is engaging in development, manufacture, commercialization and market innovative specialty generic prescription medicines as well as a over the counter medicines. Nucrogene generic pharmaceutical develop products with focus on wide range of therapeutic areas including, cardiovascular, proton pump inhibitors, anti-infective and anti-inflammatory diseases and other medical situation in the United States, Latin America, Europe and international market. Dosage forms include immediate release (IR), modified release (MR) and extended release(ER) of tablets, capsules and injectable. Nucrogene’s goal is to come up with innovations in generic medicines, improved quality of life for patients from high quality, cost effective medicines.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 42 Colonial Dr, Piscataway,new Jersey 08854,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.nucrogene.com
- Keywords
- Generic Formulations.
- HQ
- Piscataway, New Jersey
Nucrogene Questions
Nucrogene's website is http://www.nucrogene.com
Nucrogene's LinkedIn profile is https://www.linkedin.com/company/nucrogene
Nucrogene has
5 employees.
View email and phone details for 5
employees at Nucrogene.
Nucrogene's industry is
Pharmaceutical Manufacturing
Nucrogene's top competitors are
Sigmapharm Laboratories, Llc,
Bactolac Pharmaceutical, Inc.,
A&z Pharmaceutical, Inc.,
Akorn Pharmaceuticals,
Lnk International Inc.,
Sciegen Pharmaceuticals Inc,
Carnegie Pharmaceuticals Llc,
Amneal Pharmaceuticals,
Ascent Pharmaceuticals, Inc.,
Saptalis Pharmaceuticals, Llc.
Nucrogene's categories are Pharmaceutical Manufacturing
Nucrogene's founding year is 2018
